CA1329777C - Cookies containing psyllium - Google Patents

Cookies containing psyllium

Info

Publication number
CA1329777C
CA1329777C CA000577241A CA577241A CA1329777C CA 1329777 C CA1329777 C CA 1329777C CA 000577241 A CA000577241 A CA 000577241A CA 577241 A CA577241 A CA 577241A CA 1329777 C CA1329777 C CA 1329777C
Authority
CA
Canada
Prior art keywords
dough
component
sucrose
cookie
psyllium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA000577241A
Other languages
French (fr)
Inventor
Phillip Floyd Pflaumer
Edward Dewey Smith Iii
Wilbur George Hudson Jr.
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Application granted granted Critical
Publication of CA1329777C publication Critical patent/CA1329777C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A21BAKING; EDIBLE DOUGHS
    • A21DTREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
    • A21D2/00Treatment of flour or dough by adding materials thereto before or during baking
    • A21D2/08Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
    • A21D2/36Vegetable material
    • AHUMAN NECESSITIES
    • A21BAKING; EDIBLE DOUGHS
    • A21DTREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
    • A21D2/00Treatment of flour or dough by adding materials thereto before or during baking
    • A21D2/08Treatment of flour or dough by adding materials thereto before or during baking by adding organic substances
    • A21D2/14Organic oxygen compounds
    • A21D2/16Fatty acid esters
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S426/00Food or edible material: processes, compositions, and products
    • Y10S426/804Low calorie, low sodium or hypoallergic

Abstract

COOKIES CONTAINING PSYLLIUM
ABSTRACT
Disclosed are cookies containing psyllium and a method for making those cookies. The cookies may additionally contain polyol polyesters. These cookies provide an effective method for introducing psyllium into the diet to treat gastrointestinal disorders, such as constipation or diarrhea, as well as a method for introducing psyllium and polyol polyesters into the diet to reduce blood cholesterol levels.

Description

~ 329777 TFCHNICAL FIELD
This invention relates to cookies containing psyllium or psyllium and polyol polyesters, as well as methods ~or making those cookies. These cookies provide an effective method for introducing psyllium into the diet to treat gastrointestinal 10 clisorders, such as constipation or diarrhea, as well as a method for introducing psyllium and polyol polyesters into the diet to reduce blood cholesterol levels.
BACKC;ROUND OF THE INVENTION
In recent years there has been increased appreciation of the 15 benefits provided by high fiber diets. These benefits include the reduction of gastrointestinal disorders and reduction of bJood cholesterol levels. High fiber intake has even been correlated with decreased incidence of certain types of cancer. Low fat dlets also provide health benefits,. In addition to the obvious ~0 welght control benefits, it has been recognized in recent years that a low fat diet can significantly reduce blood cholesterol levels.
High blood cholesterol (hypercholesterolemia~ is a significant risk factor in cardiovascular disease. Epidemiological studies 25 have demonstrated that, with few exceptions, populations consum-ing large quantities of saturated fat and cholesterol have a rela-tively high concentration of serum cholesterol and a high mortality rate from coronary heart disease. While it is recognized that other factors can also contribute to the development of cardio-30 vascular disease, there appears to be 2 causal relationship be tween high concentrations of serum cholesterol (hypercholestero-lemia) which results in the accumulation of cholesterol in various parts of the circulatory system (arteriosclerosis) or in soft l:issues (xanthomatosis), and coronary disease and coronary mortality rates.

.. . . _ . _, . . , , . . , . . , . , . .. , .. .... , _ .

. , : : . , 1 3~9777 The art describes the use of nonabsorbable, nondigestible, polyol polyesters as cholesterol lowering agents. U. 5. Patent 3, 954, 976, Mattson, et al ., issued May 4, 1976, teaçhes pharmaceutical cornpositions for inhibiting absorption of 5 cholesterol, comprising effective unit dosage amounts of a polyol ~atty acid polyester having at least ~our C8-C22 fatty acid ester groups. U. S. Patent 4,005,195, Jandacek, issued January 25, 1977, discloses anti-anal leakage agents used in combination with liquid polyol fatty acid polyesters to provide pharmaceutical and 10 food compositions for treating andtor preventing hypercholester-olemia while avoiding undesired anal ieakage of the liquid poly-esters. U. S. Patent 4,005,196, Jandacek et al., issued January 25, 1977, discloses anti-anal leakage agents used in combination with vitamin-fortified liquid ~atty acid polyester compositions for treating andJor preventing hyp~rcholesterolemia while avoiding undesired anal leakage of the polyesters. U. 5. Patent 4,034,083, Mattson, issued July 5, 1977, comprises polyol fatty acid polyesters having at least four fatty acid ester groups which are ~ortified with fat-soluble vitamins and used in low-calorie 20 foods and in pharmaceutical cornpositions for treating and/or preventing hypercholesterolemia in animals, especially humans.
Disciosures of polyol polyestler compounds in food composi-tions include U.S. Patent 3,579,548, Whyte, issued May 18, 1971, which teaches triglyceride esters of a-branched carboxylic acids, 25 having the physical properties and utility o~ ordinary triglyceride fats but which are digested or absorbed to a lesser extent and are thus low calorie. These triglyceride esters are useful in making, for example, cakes. U.S. Patent 3,600,186, Mattson, et al ., issued August 1 7 , 1 971, discloses low calorie food composi-30 tions produced by replacing at least a portion of the fat sontentof a conventional food with a sugar fatty acid polyester or sugar ; alcohol fatty acid polyester having at least 4 fatty acid ester groups with each fatty acid having from 8 to 22 carbon atoms.
U. S. Patent 4,368,213, Hollenbach, et al., issued January 11, 35 1 g83, discloses a concentrated emulsion of non-absorbable liquid polyol polyesters and high melting fatty acids or esters thereof in ' ' - - - - - - ..... . .
- , .: , ;, ,. ,: . , , . ~. - : , .
. , . ~

water which can be diluted to a beverage. The emulsifier system comprises a polyglycerol es~er and an aliphatic glycol ester.
U.S. Patent 4,461,782, Robbins, et al., Issued July 24, 1984, discJoses low calorie bak~d goods comprising from about 12% to about 60% of a non-absorbable, non-digestible, liquid polyol poly~ster, and ~rom about 25% to about 85% microcrystalline cellu-lose or a mixture of microcrystalllne cellulose anâ flour in a cellulose:flour weight ratio of at least 1:1.
Disclosures of the polyol polyester compounds in pharmaceu-tical compositions include U.S. Patent 4,382,924, Berling, et al., issued M~y 10, 1983, which teaches edible compositions comprising edible oil or oil-like materials, a high potency, lipid-soluble sweetener, such as saccharin, and a lipid-soluble flavorant.
These compositions are particularly useful as an oral dosage form for vitamins or pharrnaceutical materials. The edible oil-like material may consist, in whole or in part, of an oily pharmaceu`
tical agent, such as polyol fatty acid polyesters having at least four C8-C22 fatty acid ester groups. U.S. Patent 4,214,054, Volpenhein, et al., issued December 23, 1980, teaches the use of polyol polyesters to detoxlfy humans and lower animals which have ingested toxic lipophillc compounds. U.S. Patent 4,264,583, Jandacek, issued April 2B, 1981, ,disc7Oses tha oral administration ; of polyol fatty acid polyesters to Idissolve radioluscent gallstones.
In this treatment regim~n, the polyesters may be administered aione or, pref~rably, in conjunction with a lithoiytic bile acid.
U. S. Patents 3,963,699, Rizzi, et al., issued June 15, 1976;
4,517,350, Volpenhein, issued May 14, 1985: and 4,518,772, Volpenhein, issued May 14~ 1985, all disclose methods of synthesis for higher polyol fatty acid polyesters.
J. E. Garbin, D. T. Forman, W. R. Eiseman, and C. R.
Phillips, Proc. Soc. Exp. E3iol. Med., 120, 744 (1965), describe the administration of psyllium (as META~AUCIL brand laxative) to human volunteers, resulting in a reduction in blood cholesterol levels. Also, see Forman, et. al., Proc. Soc. Exp. Biol. Med., 127, 1060-1063 ( 1968) .

' : ~ .. :

Generaliy, psyllium, whether used for controlling consti-pation or diarrhea, or for reducing blood choles~eroi levels, is introduced Into the d3et by dispersing it in water or an ~queous beverage whlch Is ingested by the user.
Psyllium mucilloid contains natural mucillage and normally forms a gelatinous mass on contact with water. It also exhibits poor dispersibility and mixability in water. The numerous individual particles tend to agglomerate when psyllium mucilloid is mixed in water Hydration takes place over the surfac~ of such 10 agglomerated aggregates to form gei-coated lumps~ the interiors of which are still substantiaily dry, and these lumps are extremely difficult to disperse. This effect is aggravatedl by the fact that psyllium has a tendency to float on the surface of the water, allowing partially dissolved particles to agglomerate into large masses. Such imperfect dispersions are generally not considered to be palatable. In addition, even when properly dispersed, the~
taste and texture of psyllium mucilloid are undesirable to many persons .
A number of methods have been suggested for obviating 20 these problems. Historically, psyllium seed preparations have been formulated to contain equal parts of active bulk laxative and 1 a sugar as a means of promoting dispersion. These products are undesTrable to many persons because of their hlgh sugar and calorie content.
U.~. Patent 3,~55,714, Bishop et al., issued July 15, 1969, discloses a method for providing water-soluble gums having improved water dispersibility comprising coating the gums with certain water-soluble cellulose ethers, water-scluble cellulose esters, and water-soluble mixed cellulose esters which do not agglomerate when added to water or have less of a tendency to agglomerate than the materials being coated therewith. U. S.
Patent 4,321,263, Powell et al., issued March 23, 1982, discloses a method for rendering psyllium powder more easily dispersed in water by wetting the psyllium particles with an alcoholic solution of at least one polyethylene glycol and polyvinylpyrrolidone and granulating the thus-coated particles.

.. ., . . . . . .. _ .. . . .

.~ , .

1 32~777 U. S. Patent 4,565,702, Morley, et al., issued January 21, 1986, teaches a dietary fiber composition prepared by coating an insoluble fiber with a soluble fiber. The insoluble fiber may be psyllium. The dietary fiber composition can be used to prepare low calorie, high fiber content dietary food products.
Finally, European Patent Application 144,644, published June - 19, 1985, discloses a composition oomprising from about 25~ to about 100~ ~by weight) total dietary fiber selected from psyllium, and a grain, fruit, or vegetable source, wherein psyllium comprises from about 10~ to about 809~ of the fiber. The dry blend or high fiber food product base is incorporated into suitable compositions to provide a psyllium high fiber drink mix or an extruded psyllium high fiber bar or puff which may additionally contain sweeteners, flavoring agents, protein sources, surfactants, wetting agents, preservatives, and the like.
Cookies or biscuits might provide a useful way to introduce psyllium into the diet. However, attempts to incorporate psyllium into baked goods have historically met with difficulty due to the mucillaginous nature of psyllium. If the psyllium is hydrated before the compositions are bakled, an undesir able product resul~s. Not only is the product clifficult to work with, but the resulting b~ked product has an und~sirable taste and ~exture.
It would be most desirable to make a palatable psyllium-containing cookie in which the psyllium does not subs$antially hydrate during th~ mixing, forming, or baking process, and does not substantially hydrate in the mouth upon eating.
An object of an aspect of the present invention is to provide a m~thod for making such a psylliumrco~taining c ~ e.
An object of an aspect of the present inven~ion is to provide a c ~ ition and method for making a palatable psylliumr and polyol polyester-containing oookie.
An object of an aspect of the present invention is to prcvide a method for reducing blood cholesterol in a patient in need of such treatment, comprising the administration to the patient of said psyllium~conta ming or said psyllium, and polyol polyester-containing cookie.

~ 1 , ,-. . : : : .
, ~ . .

.

1 32q777 An object of an aspect of the present invention is to provide a method for treating gastrointestinal disorders (such as constipation or diarrhea) in a patient in need of such treatment, comprising the administration to the patient of said psyllium-containing cookie.
SUMMARY OF THE INVENTION
The present invention relates to a method for making a psyllium-containing cookie dough which comprises the steps of:
~ a) combining from about 3% to about 15%, by weight of the dough, of a liquid component selected from the group consisting of water, fresh egg and mixtures thereof, with from about 0.6~ to about 35%, by weight of the dough, of a dry ingredient component selected from the group consisting of flour) sugar, non-pre-gelatinized starch, egg solids, protein solids, and mixtures thereof;
(b) combining from about 10% to about 35%, by weight of the dough, of a flu:id shortening component with the mixture of (a); and (c) combining the mixture of (b) with from about 5% to about 30%, by weight of the dough, of a psyllium component, and other conventional cookie components to form said cookie dough.
The present invention also relates to a composition and method for making a psyllium- and polyol polyester-containing cookieO
The present invention further relates to methods for treating hypercholesterolemia and gastrointestinal disorders comprising oral administration of said cookies to a patient in need of such treatment.
Other aspects of this invention are as follows:
A method for making a psyllium-containing cookie dough comprising the steps of:

. ~ , , , 1'~

:

.
.. . .
,. . .

1 32q~77 6a (a) combining from about 3% to about 15%, by weight of the dough, of a liquid component selected from the group consisting of water, fresh egg, and mixtures thereof, with from about 10% to about 30%, by weight of the dough, of a sugar component;
(b) combining from about 10% to about 35%, by weight of the dough, of a fluid shortening component with the mixture of (a);
(c3 mixing together from 0% to about 30%, by weight of the doughl of a flour component, from 0% to about 30%, by weight of the dough, of a starch component, from about 0.1% to about 2%, by weight of the dough, of a dry egg white component, and from about 5%
to about 30%, by weight of the dough, of a psyllium component, and then combininy this mixture with the mixture of (b).
A cookie comprising:
(a) from about 5% to about 30% of psyllium;
(b) from about 10% to about 35% of a shortening 20 component comprising from about 10% to about 100% of a premelted, nondigestible, nonabsorbable polyol polyester;
(c) from about 25% to about 50% of a sugar component;
(d) from o% to about 30% of a flour component;
(e) from 0% to about 30% of a starch component;
(f) from o% to about 15% of an egg component;
(g) the remainder being conventional cookie additives.
A cookie comprising:
(a) from about 8% to about 25% of psyllium;
(b) from about 15% to about 35% of a polyol polyester selected from the group consisting of sucrose octaoleate, sucrose octalinoleate, sucrose octastearate, sucrose octapalmitate and mixtures thereof;
(c) from about 30% to about 45% of sucrose;

:; : . . .
-~ , ' ~ " ': ' , ~ ; .: . i . . ~ ' :.

;, . .

t 3~777 6b (d) from about 0% to about 15% of an all-purpose wheat flour;
(e~ from about 1% to about 5% of pregelatinized starch;
(f) from about 0.1% to about 2% of dry egg white solids;
(g) the remainder being conventional cookie additives.
Products produced by the processes set out hereinabove.
DETAILED DESCRIPTION OF THE INVENTION
The present invention provides an effective method for incorporation of psyllium into a cookie composition.
Most conventional cookie recipes are useful in the present invention, provided the specific procedure described herein for incorporation of psyllium is followed. Specifically, the flour and starch components must be manipulated; and the order in which the ingredients are combined must be altered, to allow for incorporation of A

., . . ~ . ,~ . . .
.~ ; . ............... .. ,: . ., .
. .. . . . . . .

.

the psyllium. Particularly useful are cookie compositions tending to be higher in fat and sugar. Especially preferres:l is a peanut butter cookie composition.
The psyllium used in the practice of this invention comes from psyllium seed, from plants of the Planta~o genus~ Various species, such as Plantago lanceolate, P. rugelii, and P. major, are known. Commercial psyllium includes the French (black;
Plantago indica), Spanish (P. psyllium~ and Indian (blond; P.
ovata). The gum content of the psyllium varies: French psyl-lium, 11.8%; Indian psyllium, 30~9%; and German psyllium, 11.59~.
Indian tblond) psyllium is pre~erred for use herein.
The psy!lium gum (or "hydrophilic mucilloid"3 is located in the seed coat, from which it is readily extractable by water.
Thus, intact or macerated seeds can be used in the practice of th is invention; however, it is more typical to remove the seed coats from the rest of the seed by, for example, slight mechanical pressure, and then to use only the coats as a source of the gum.
I n the practice of l~he present invention it is convenient and typical to use macerated seed coats in the final formulation as the source of the psyllium gum. Preferably, the seed coats are not finely ground. From about 10% to about 35%, preferably from about 15% to about 3096, by weight of the cookie dough comprises psyl lium .
The cookies of the present invention also comprise conven-tional cookie ingredients including, sugar, flour, shortening, egg and other conventional additives.
Ordinary granulated sugars are satisfactory for use in making the cookies of the present invention. These include sucrose, dextrose, maltose, fructose, brown and invert sugars, alone or in combination. The preferred sugars are brown sugar anci granulated sucrose. Corn syrups may also be used as the sugar component of the present invention, however, the liquid component must be adjusted to compensate for the water in the syrup. Powdered sugars can also be used. The amount of sugar useful in the compositions of the present invention is at conven-tional cookie composition levels, generally from about 20% to about , .. . , ,.. .... ; .. ... ..
, : .
.. , . .
. - :, ' . ' ' . :~ ~ , ' : :
. ~: :

t 329717 50%, preferably from about 2596 to about 4û%, by weight of the cookie dough.
In the cookies described herein, psyllium cannot be used to simpJy substi~ute for the entire flour or starsh component conven-tionally used in cookie compositions. If this were done, the result would be a crumbly cookie that would not stay in one piece. Furthermore, the psyllium generaîly cannot be added in addition to the typical ingredient levels for conventional cookie compositions. This would prevent inclusion of necessary leve3s of key cookie components. Thus, the cookies of the present composi-tion are made with psyllium and a reduced level of flour.
The flour for use in making the cookies of the present invention may be any finely comminuted meal of any cereal grain or edible seed, or mixtures thereof, as are known by one skilled - 15 in the art of baking. Typical non-llmiting examples include wheatflour, barley flour, rye flour, cornstarch and corn flour, triticale, and also the so-called synthetic flours, which incorporate such materials as starch and soy protein isolate, with or without heat andlor steam treatment. The wheat flours are most typically employed in baking. They consist o~ several types including hard red spring, hard red winter, soft red winter and white winter and spring. These flour ~ypes are distinguished by differences in gluten qualTty, water absorption and protein content. Protein in these flours can vary from about 796 to about 1496, with the soft wheat flours havir,g protein contents at the lower end of that range and the hard winter wheat flours having protein contents at the upper end of that range. Preferably the flour used is a general purpose wheat flour. The cookie dough of the present invention comprises from about 4% to about 25%, preferably from about 59~ to about 2096, fiour.
A starch source may be substituted for all or part of the flour. The starch can be any of tlhe common food starches, for example, potato starch, corn starch, wheat starch, rice starch, barley starch, oat starch, tapioca starch, arrowroot, and sago 35 starch. Modified starches can also be used. Preferably, the starch is pregelatinized, whlch helps to hold the baked cookie ., ~
.

.' : ~ ' ., 1 32q777 together, partkulariy at a reduced level of flour. Preferably, starch is substituted for from about 10% to about 50~ oF the flour component, thus comprising from about 1% to about 5% of the cookie dough composition.
The shortenings that can be employed in making the cookies of the present invention are well-known to those skilled in the art of baking and include sotid or plastic, as well as liquid or semi-fluid, glyceride shortsnings derived from animal, vegetable fats and oils including synthetic211y prepared shortenings. These glycerides can contain saturated or unsaturated "long-chain" acyl radicals having from about 12 to about 22 carbon atoms such as lauroyl, lauroyleoyl, myristoyl, myristol~oyl, paJmitoyl, palmitoleoyl, stearoyl, oleoyi, linoleoyl, linolenoyl, arachidoyl, arachidonoyl, behenoyl, erucoyl, and the like and are generally obtained from edible oils and fats such as corn oil, cottonseed oils, soybean oil, coconut oii, rapeseed oil, peanut oil, olive oil, palm oil, palm kernel oii, sunflower seed oil, safflower oil, lard, tallow and the like. These glyc~r ides can also contain, in part, one or two short-chain acyl groups having from 2 to about 6 carbon atoms such as acetyl, propanoyl, valeryl, and caproyl;
they can be prepared by random or low-temperature interesterification reactions of fatty triglyceride containing oils and fats such as interesterified or rearranged cottonseed oil and lard; and they can be otherwise ~ormed by various organic syntheses.
S~e preferred shortenings are soybean-based short~ir~s or oils, hydrogenated scybean-based short~ir~ or oil, corn oil, palm oil, hydrogenated palm oil, lard and tallow oils. Of these, "(~risco"~M
~rarxl shortenir~ or oil, ~ ich is soybean-based, is preferred.
"Crisoo" oil or shortening is ccmmercially-available from The Procter Gamble CGmpany. It is preferred that the shortenin~ use in the present invention be in fluid form, i.e., liquid at room temperature of melted, when added to the other Lngredients. A shortening which may be use~ul in the present invention is that disclosed in U.S.
Pa~ent No. 4,664,921, issued May 12, 1987 to The Procter & Gamble ~y.
;~

:, ~, , ~, ... .

1 32~777 This reference discloses a shortening which has a very low fat solids content. ( If polyoi polyesters are used in the present invention, this shortening preferably should not be used because of its low fat solids content.) From about 1 OB to about 35%, preferably from about 15% to about 32%, by weight of the cookie dough comprises shortening.
Preferably, the shortening will contain an emulsifier which comprises from about 3% to about 3û% of the shortening system.
- Suitable emulsifiers are lactylated mono- and diglycerides, lU propylene glycol monoesters, polyglycerol esters, sorbitan esters, diacetylated tartaric acid esters of mono- and diglycerides, citric acid esters of monoglycerides, stearoyi-2-lactylates, polysorbates, suceinylated monoglycerides, acetylated monoylycerides, ethoxylated monoglycerides, lecithin, sucrose monoester, and mixtures thereof. Polyglycerol esters suitable for use in the present invention have an average of from about 2 to about 10 giycerol units and from 1 to 3 fatty acyl groups containing from about 14 to about 18 carbon atoms per glys~rol moiety.
A preferred shortening/emulsifier system is that disclosed in U.S. Patent 4,456,626, Nelson et al., issued June 26, 1984. The shortening disclosed therein contains an emulsifier consisting essentially of a hydrophilic polyglycerol monoester and a pro-pylene glycGI monoester, wherein the fatty acids used to esterify the polyglycerol ester and propylene giycol esters have from ;!5 about C~ C22 carbon atoms, the ratio of propylene glycol mono-ester to polyglycerol ester being from 2 :1 to 7 :1 . The remainder of the shortening sytem is fats, oils or hydrogenated ~ats and oil.
In a preferred embodimen~ of the cookie of the present in-vention, the shortening is replaced, completely or partly with a ~ 30 polyol polyester, ; The nonabsorbable, nondigestible polyol polyesters (or, simp7y, polyesters ~ employed in this invention comprise certain poiyols, especially sugars or sugar alcohols, esterified with at Ieast four fatty acid groups. Accordingly, the polyol startins material must have at least four esterifiable hydroxyl groups.
See e.g., U.S. Patent 3,579,548, Whyte, issued May 18, 1971.
;'' ~ A
.. . .. . .

,.~ - , .

1 32~777 Examples of preferred polyols are sugars, including monosascharides and disaccharides, and sugar alcohols. Examples of mnnosaccharides containing four hydroxyl groups are xylose and arabinose and the sugar alcohol derived from xylose, which has five hydroxyl groups, i.e., xylitol. (The monosaccharide, erythrose, is not suitable in the practice of this invention since it only contains three hydroxyl groups; but the sugar alcohol derived from erythrose, i.e., erythritol, contains four hydroxyl groups and accordingly can be used. ) Suitable five hydroxyl group-containing monosaccharides include galactose, fructose, and sorbose. Sugar alcohols con-taining six -OH groups derived from the hydrolysis products of sucrose, as well as glucose and sorbose, e.g., sorbitol, are also suitable. Examples of disaccharide polyO15 which can be used include maltose, lactose, and sucrose, all of which contain eight hydroxyl groups.
Preferred polyols for pr~paring the polyesters for use in the present invention are selected from the group consisting of erythritol, xylitol, sorbitol, glusose and sucrose. Sucrose is especially preferredO
The polyol starting material having at least four hydroxyl groups must be esterified on at least four of the -OH groups with a fatty acid containing from about 8 to about 22 carbon atoms.
Examples of such fatty acids include caprylic, capric, lauric, myristic, myristoleie, palmitic, palmitoleic, stearic, oleic, ricinoleic, linoleic, linolenic, eleostearic, arachidic, arachidonic, behenic, and erucic acid. The fatty acids can be derived from naturally-occurring or synthetic fatty acids; they can be saturated or unsaturated, including positional and geometrical isomers, depending on the desired physical properties fe.g., liquid of a desired viscosity or solid) of the polyol fatty acid polyester compound being prepared.
Fatty acids per se or naturally-occurring fats and oils can serve as the source for the fatty acid component in the polyol fatty acid polyester . For example, rapeseed oi l provides a good source of C22 fatty acids. The C16-C18 fatty acids can be ,~

obtained from tallow, soybean oil, and cottonseed oil. Shorter chain ~atty acids can be obtained from coconut, palm kernel, and babassu oils. Corn oii, lard oil, palm oil, peanut oil, safflower seed oil, sesame seed oil, and sunflower seed oil are examples of other natural oils which can serve as the source of the fatty acid used to prepare the polyesters herein.
Preferred fatty acids for preparing the polyol polyesters herein are the C14 to C18 acids, and are most preferably selected from the group consisting of myristic, palmitic, stearic, oleic, and linoleic fatty acids. Thus, natural fa$s and oils which have a high content of these fatty acids represent preferred sources for the fatty acid component, i.e., soybean oil, olive oil, cottonseed oil, corn oil, tallow and lard.
The polyol fatty acid polyesters useful in this invention must contain at least four fatty acid ester groups. Polyol fatty acid polyester compounds that contain three or less fatty acid ester groups are digested and the products of digestion are absorbed from the intestinal tract in much the same manner as with ordinary triglyceride fats, whereas the polyol Fatty acid polyester compounds that contain four or rr)ore fatty acid ester groups are substantially nondigestible and consequently nonabsorbable by the human body. It is not necessary that all of the hydroxyl groups of the polyol be esterified with fatty acid, but it is preferred that the polyester contain no more than two unesterified hydroxyl groups. Most preferably, substantially all of the hydroxyl groups of the polyol are esterified with ~atty acids, i . e., the compound is substantially completely esterified. The fatty acids esterified with the polyol molecule can be the same or mixed.
To illustrate the above points, a s(Jcrose fatty triester would `I 30 not be suitable for use herein because it does not contain the required four fatty acid ester groups. A sucrose tetra-fatty acid ester would be suitable, but is not preferred because it has more than two unesterified hydroxyl groups. A sucrose hexa-fatty ' acid ester would be preferred because it has no more than two 35 unesterified hydroxyl groups. Highly preferred compounds in : . .. .
~ , . . - . .
. .
:.' . : . . .. , '~
.
, ~' . ' .

which all the hydroxyl groups are esterified with fatty acid include the sucrose octa-fatty acid esters.
In any given polyol ~atty acid polyester compound, the fatty acid ester groups can be selected on the basis of the desired physical properties of the compound. For example, the polyol polyesters which contain unsaturated fatty acid ester groups andlor a preponderance of short chain, eOg., C12, fatty acid ester groups are generally liquid at room temperature. The polyols esterified with longer chain andlor saturated fatty acid groups, such as stearoyl, are solids at room temperature.
The following are nonlimitin~ examples of specific polyol fatty acid polyesters containing at least four fatty acid ester groups suitable for use in the present invention: glucose tetraoleate, glucose tetrastearate, the glucose tetraesters of soybean oil fatty acids, the mannose tetraesters of mixed tallow fatty acids, the galactose tetraesters of olive oil fatty acids, the arabinose tetraesters of cottonseed oil fatty acids, xylose tetralinoleate, galactose pentastearate, sorbitol tetraoleate, the sorbitol hexaesters of olive oi1 fatty acids, xylitol pentapalmitate, the xylitol tetraesters of substantially completely hydrogenated cottonseed oil fatty acids, sucrose tetrastearate, sucrose pentastearate, sucrose hexaoteate, sucrose octaoleate, the sucrose octaesters of partially or substantially completely hydrogenated soybean oil ~atty acids and the sucrose octaesters of peanut oil fatty acids.
As noted above, highly preferred polyol fatty acid esters are those wherein the fatty acids con tain from about 14 to about 1 B
carbon atoms and are thus derived from such natural materials as soybean oil and olive oil. Examples of such compounds are the erythritol tetraesters of olive oil fatty acids, erythritol tetraoleate, xylitol pentaoieate, sorbitol hexaoleate, sucrose octaoleate, and the sucrose hexa-, hepta- and octaes~ers of soybean oil fatty acids, partially or substantial1y wholly hydrogenated .
Generally, the sucrose polyester component used to prepare the cookie dough of the present invention comprises the product . .
: '' '.'' '' ' ' '' ' .. . .

of an esterification reaetion of a sucrose molecul~ with several different fatty acid salts or esters and is thus a mixture of several individual sucrose polyesters, each of which may include several different fatty acid moieties. Preferably at least 50% of the sucrose polyester component comprises octaesters, no greater than 10% comprises hexaesters, and the remainder comprises hepta-esters .
The polyol fatty acid polyesters suitable for use herein can be prepared by a variety of methods well-known to those skilled in the art. These methods include: transesterification of the polyol with methyl, ethyl or glycerol fatty acid esters using a variety of catalysts; acylation of the polyol with a Fatty acid chloride; acylation of the polyol with a ~atty acid anhydride; and acylation of the polyol with a fatty acid, per se. As an example, the preparation of polyol fatty acid esters is described in U . S.
Patent 2,831,854, incorporated herein by reference. The most highly preferred methods of preparing the polyol polyesters used herein are disclosed in U.S, Patents 3,963,69~; 4,517,360 and 4,518,772 .
Specific, but nonlimiting, examples of the preparation of polyol fatty acid esters suitable for use in the practice of this invention are as follows.
, Erythritol tetraoleate - Erythritol and a five-fold molarexcess of methyl oleate are heated at 1 80C, under vacuum, with 25 agitatinn, in the presence of sodium methoxide catalyst over two reaction periods of several hours each. The reaction product (predominantly erythritol tetraoleate~ is refined in petroleum ether and crystallized three times from several volumes of acetone at ,, 1~.
Xylitol pentaoleate - Xylitol and a five-foid moiar excess of methyl oleate in s~imethylacetamide (DMAC) solution are heated at 1 80C for five hours in the presence of sodium methoxide catalyst, under vacuum. During this time the DMAC is removed by distillation. The product ~predominantly xylitol pentaoleate) is - - 35 refined in petroleum ether solution and, after belng freed of ~q ~

",' , ~ ". ~ . . , .

,5 petroleum ether, is separat~d as a liquid layer four times from acetone at ca. 1C and twice from alcohol at ca. 10C.
Sorbitol hexaoleate is prepared by essentially the same procedure used to prepare xylitol pentaol~ate excep~ the sorbitol is substituted for xylitol.
SucrDse octaoleate is prepared by substantially the same procedure as that used to prepare erythritol tetraoleate except that sucrose is substituted for erythritol.
From about 096 to about 100~, preferably from about 10~ to about 100%, most preferably from about S096 to about 100%, by weight of the shortening component, i.8., from 0 to about 35%, preferably from about 1096 to about 32%, by weight of the cookie dough, can comprise these polyol polyesters.
Fat-soluble vitamins can optionally be us~d to fortify the foregoing polyesters. It wlll be appreciated that commercial preparations of the appropriate vitamins and/or appropriate vitarnin mixtures which provide vitamins A, D, E and K can be used herein. See U.S. Patent 4,034,083, Mattson, issued July S, 1977 for details of the role of these vitamins in metabolism and t~eir use ~n can~nation with polyesters of the ~pe used ~n this i~ tion.
The amount of the individual fat-solubie vitamins used to fortify the present compnsitions can vary with the age of the recipient, the dosage regimen us@d, and the amount of the vitamin ingested from other dietary sources. For example, in younger, growing children or in pregnant females it is recognized that larger amounts of any given vitamin should be ingested to supply optimal nutritional benefits than are needed wlth adult males. If the user of the present compositions happens to ingest foods which are extremely rich in a given fat-soluble vitamin, iess of that vitamin need be used in the present compositions to insure adequate intestinal uptake for good nutrition. In any event. an attending physician can, if so desired, measure the amount of fat-soluble vitamins in the plasma. Based on these data, the appropriate type and safe and ~ffective amount of fat-soluble :

~ . , ' . : ... ..
:

1 32~777 vitamin used to ~ortify the polyesters herein can then be deter-mined on an individual basis.
More simpiy, the formulator of the compositions herein can fortify the poiyesters with a recommended daily allowanca ( RDAl, or increment or multiple of an RDA, of any of the fa~-soluble vitamins to insure that the user of the compositions will maintain a nutritionally adequate uptake of said vitamins. For example, with vitamin A a daily amount in the range olF 20 international units (I.U.) to abou~ 57 I.U. per kilogram of body weight can be employed. With vitamin D, fortification of the compositions to provide about 40~ i . U., total, per day is ample. When supple-menting with vitamin E, the amount of the vitamin optimal for dietary intake ranges from 3-6 1. U . for infants to 25-30 1. U .
total, per day for adults. When supplementing with vitamin K, it is more difflcult to estimate the amount to be ingested to provide adequate nutrition since the microorganisms living in the intestine can synthesize this vitamin. However, it is known that ingestion of from 0.5 mg.-1 mg. of vitamin K per day will prevent insuffi-ciency.
Anti-anal leakage agents may also optionally be used in combination with the polyesters to avoid undesirable anal leakage of the liquid polyesters. Though these agents may be used in the present invention, the combination of the polyesters with the psyllium may obviate the need ~or these anti-anal leakage ayents.
These agents may somprise edible C12 and higher saturated fatty acids, and their edible salts; edible, digestible sources of C12 and higher saturated fatty acids: edible, non-absorbable, non-digestible solid polyol fatty acid polyesters having at least 4 fatty acid ester groups, wherein the polyol is selected from the group consisting of sugars and sugar alcohols containing from 4 to 8 hydroxyl groups and wherein each fatty acid group has from about 8 to about 22 carbon atoms; and edible, non-digestible esters of alpha-branched chain C1 0-Cl 8 fatty acids. Preferably, the anti-anal leakage agent is selected from the C16-C18 saturated fatty acids. A more detailed discussion of these agents can be found in U . S . Patent 4, 005 ,195, Jandacek, issued January 5, ~.
.. ..
,.

1 ~2~777 1977. If the anti-anal leakaga agen~ is included in the c~ositions of the present ~nve3~tion, it is included at frcm abou~ 1% to a~out 10%
of the cookie dou3h c~osition.

Although eggs, or a suitable protein substitute, are not a critical ingredient of the cookies of the present invention, eggs are preferably included to impart flavor, richness and color to the cookies. Fresh whole eggs are preferred for making the cookies of the present invention. Alternatively, egg solids, 10 particularly egg albumen and dried yolk, may be used in baking the products disclosed herein. Soy isola~es, whey protein concentrates, or other egg substitutes may also be used herein in combination with, or in place of, the egg solids. Such substitutcs are well-known to those skilled in the art of baking.
From about 0% to about 159~ by weight of the cookie dough, can comprise egg or egg substitute. When fresh whole egg is used, levels at the high end of this range are appropriate, whereas when dried egg solids are used lower levels are generally used.
ll he covkie dough of the present invention, as with con-20 ventional cookie dough, requlres a liquid component. From about 3~ to about 15%, by weight of the dough, comprises the liquid component added either via fresh egg (e.g., egg yolk, egg white, or whole egg~, water, or a fresh egg plus water mixture.
When fresh egg Is used as the liquid component, it is generally 25 included at from about 10~6 to about l 596 of the dough. When water is utili~ed as the li~uid component it is gen~rally included at from about 3% to about 596 of the dough.
The liquid componen~ it is generally included at from about 3% to about 596 of the dough. The "conventional additives" useful 30 in making the cookies of the present invention include ingredients such as leavening agents, flavors, and flavor additives, colors, nutrients, antioxidants, and antimicrobial agents.
The chemical leaYening agents can comprise a baking soda, e.g. sodium, potassium, or ammonium bicarbonate, andlor a 35 baking acid, preferably sodium aluminum phosphate, monocalcium phosphate, dicalcium phosphate or mixtures thereof. The A~

~, , 1 32~777 selection of the leavening system is within the knowledge of one skilled in the art. From 09~ to about 2%, preferably from about 0.1% to about 2%, of the cookie dough of the present invention will typicaily be leavening agent.
S The flavor additives can be of a type that remain as whole pieces in the cookie. Such additives include, but are not limited to, chocolate, peanut butter or butterscotch chips or chunks, fruit or fruit-flavored bits, such as blueberry, strawberry, or citrus flavored bits as disclosed in U.S. Patent 3,794,741, Weigle, issued Fe~rua~ 26, 1974; or oth~r fruit flavor~d bits, such as ch~rry, blackberry, apricot, raisin, date, or apple. Cereals may also be used, such as bran or oatmeal, as may nutmeats including the whole or chopped meat of any edible nut including walnuts, black walnuts, hickory nuts, hazel nuts, brazil nuts, peanuts, macadamia nuts, pecans, almonds, cashews, coconut and the like.
From 0P~ to about 30% of the cookie dough can be such additives.
Other flavor additives may be incorporated into the cookie dough prior to baking to add flaYor, aroma, and color to the final baked cookie. Examples, include spices, such as cinnamon, mace, nutmeg, caraway, anise, allspice, poppy seed, coriander, ginger, cloves, fennel, and salt; and flavorings, such as banana, orange, lernon, mint or vanill~, at levels up to about 10~ of the cookie dough. Honey or molasses rnay also be used in the present invention at levels up to about 15%. Mixtures of these flavorings and whol~ piece components can be added to provide a variety of desirable products. Addition of peanut butter is preferred in preparing ths cookie dough because the cookies of the present invention are well~suited to compositions with high oil contents.
Up to about 30%, preferably from about 10% to about 25%, by weight of the cookie dough of the present invention comprises peanut butter. The exact amount added for any of these flavoring components (whether they are of the type that is blended into the composition or the type that remain as whole pieces) will depend on personal preferenee and on what particularly is being added.
-~ _ . .. . .. . .. . .

1 32~777 Preferred cookies of the present invention comprise:
(a) from about 5% to about 309~ of psyilium;
lb) from about 10~ to about 35% of a shortening component comprising from about 1096 to about 10096 of a premelted, non-5 digestible, nonabsorbable polyol polyester:
lc3 from about 25% to about 50% of a sugar component;
(d) from about 096 to about 30% of a flour component;
(e) from about 0% to about 30% of a starch component;
(f) from about 096 to about 1596 of an egg component;
(9) the remainder being conventional cookie additives.
A particularly preferred cookie has the foliowing composition:
(a~ from about 8% to about 2596 of psyllium:
1 b) from about 15% to about 35~ of a polyol polyester selected from the group consisting of sucrose octaloeate, sucrose octalinoleate, sucrose octastearate, sucrose octapalmitate and mixtures thereof;
(c) from about 30% to about 45% of sucrose;
(d) from about 0% to about 15~ of an all-purpose wheat fiour;
(e) from about 1% to about 596 of pregelatinized starch;
(f) from about 0.196 to about 296 of dry egg white solids;
(g) the remainder being conventional cookie additives.
METHOD OF MAK I NG
Incorporating psyllium into a cooki involves more than just mixing the desired amount of psyllium into a conventional cookie composition. If psyllium is added this way, the psyllium wili hydrate and ~esult in a less palaEable cookie. The present in-vention provides a method for incorporating the psyllium in a way that avoids hydration of the psyllium during the mixing, forming and baking of the cookie, thereby forming an aesthetically-appealing, more palatable psyllium-containing cookie.
The method of the present invention for making a psyllium-containing cookie comprises "tying-up" the water in the cookie dough system with part or all of the dry ingredient components in the dough, prior to mixin~ in the other cookie dough ingredients, particul~rly the psyllium. Mixing the dough in this way reduces the water availability in the cookie dough, th~reby inhibiting hydration of the psyllium during the mixing and baking process.
The dry ingredients which may be used to serve this function include sugar, flour, non-pre-gelatinized starch, egg solids, 5 protein solids or mixtures thereof. Ali or part of these dry ingredients in the cookie may be used for this purpose. Those dry ingredients, or portions thereof, which are not used to tie-up the water may be added to the cookie dough at a later point in the mixing process~
The method of the present invention comprises a premixing step during which the liquid components of th~ dough (i.e., water, fresh egg or water plus fresh egg mixture3 are mixed with the dry ingredient component select~d from sugar, flour, non-pre-gelatinized starch, egg solids, protein solids, or mixtures 15 thereof. It is pre~erred that the dry ingredients used in the premix step be selected from sugar, flour or mixtures thereof.
Preferably, the dry ingredient component that is pre-mixed with the liquid component comprises part or all of the sugar used in the cookTe dough. The sugar used in the pre-mix step 20 comprises from about 10~ to about 309~ by weight of the dough.
U~ilization of the sugar in this pre-mixing step assures distribution of all of the cookie ingredients In the dough and additîonally makes the dough ealsier to handle and form. Most preferably, the dry ingredient component is sucrose. As an 25 alternative to actually mixing sugar with water in the prem~x step, it is possible to utilize a preformed mixture of sugar and Iiquid, as would be the case with honey or corn syrup. The use ; of these pre-formed mixtures is intended to fall within the present invention. Pre-gelatinized starch should not be included 30 in the dry ingredient component of the prembc ~aithough it may be included in latter stages of the mixing) because it ties up the Iiquid component too tightly resulting in a less acceptable cookie.
The liquid component in this pre-mixing step comprises from - about 3~ to about 15% by weight of the dough. As described 35 supra, the liquid component of the cookie dough may comprise water, fresh egg, or a mixture of water and fresh egg. The dry "' .

ingredient component in this pre-mixing step comprises from about 0.6% to about 35% by weight of the dough.
This premixture is then combined with a fluid shortening cornponent, as described hereinbefore, in such an amount that the 5 shortening component comprises ~rom about 10% tb about 35~ by weight of the final cookie dough. If the shortening is not already in fluid ~orm, it should be melted before it is combined with the premix. The inelusion of the shortening at this point in the process allows the cookie dough to be easily worked in 1 û conventional mixing equipment. Preferably the shortening comprises a hydrogenated soybean-based shortening.
The pre-mixJshortening mixture may then be combined with the oth~r conventional cookie components and the psyllium to provide the cookie dough of the present invention. More 15 specifically, this mixture is combined with from about 0% to about 2%, by weight of the dough, of a leavening component; fron~
about 0~ to about 596, by weight of the dough,, of pre-gelatinized starch; any remaining dry components (e.g., sugar, flour, non-pre-gelatinizeci starch, egg or protein solids) that were not 20 pre-mixed with the water (it is possible, for example, to use part of the total sugar in the pre-mix step and add the remainder of the sugar at this point); from about 0% to about 30%, by weight of the dough, of peanut hutter andlor other flavoring additives, and from about 59~ ~o about 3096, by weigh~ of the dough, of the 25 psyllium compor-ent~ Dry egg solids are, preferably, added to the cookie dough after the pre-mix step has been completed.
The order of mixing these additional components with the pre-mixlshortening mixture is not critical. However, to provide a dough which has even distribution of components and which is 30 particularly easy to handle and form the components are combined as follows. The flour, non-pre-gelatinized starch, or protein (e.g., dry egg solids) not utilized in the liquidldry ingredient pre-mixing step, the leavening agent, starch, and the psyllium are mixed together and then mixed in with the pre-mix/shortening 35 mixture. Any remaining sugar not utilized in the tiqlJidJdry ingredient premix is then mixed in. Finally, peanut butter or any other flavoring additives are added.
;

, ... . , ; , ~ ,-:, . :
.~.

l"he cookie ingredients can be mixed using any conventional batch cookie mixing equipment, for example, a Hobart mixer.
Mixing the e~lcie ingredients in this way minimTzes hydration of the psyllium in the mixing process. Combining the specified dry ingredients, especially sugar, with the lir:~uid component, especially water, before combining with the psyllium minimizes the water availability so that the water does not hydrate the psyllium when the cookie ingredients are mixed. This enables the creation of a psyllium-containing cookie which has a texture similar to that of a conventional cookie. Furthermore, mixing the ingredients in this way slows undesireable hydration of the psyilium in the mouth upon eating. Thus, the cookies made by this method have taste and mouth~eel similar to conventional cookies.
A preferred method o~ making the cookie of the present invention inciudes the following steps:
(a) combining from about 3~ to about 159~, by weight of tha dough, of a liquid component seiected from the group consisting of water, fresh egg, and mixtures thereof, with from about 1096 to about 3096, by weight of the dough, of a 2û sugar component;
tb) combining from about 10% to about 35%, by weight of the dough, of a fluicl shortening component with the mixture of ta~;
(c) mixing together from about 0% to about 30%, by weight of the dough, of a flour cornponent, from about 096 to about 30%, by weight of the dough, of a starch component, from abol~t 0.19~ to about 2%, by weight of the dough, of 3 dry egg whTte component, and from about 5~ to about 30%, by weight of the dough, of a psyllium component, and then 3U combining this mixture with the mixture of (b).
From about 10 9 to about 30 g portions of the cookie dough prepared by the present method are placed eveniy spaced on a conventinnal baking sheet and baked using radiant, conductive or convective exposure to energy of a type which imparts thermal ,~

: ; :
.

l 32q777 energy to the product being baked, such as conventional, con-vection, microwave or combinations thereof. Baking times and temperatures are dependent on the type of oven used. General-ly, . the cookies are baked at temperatures from about 300F
(149C) to about 375F (190C) for from about 5 minutes to about 1 5 minutes.
The method of the present invention for making a psyllium and polyol polyester-containing cookie is basically the same as that for making the psyllium-containing cookie except that the shortenin~ is replaced, in whole or in part, with the desired poiyol polyester. The only difference in the method is that the polyoi polyester ~preferably sucrose octaoleate, sucrose octalin-oleate, sucrose octapalmitate, sucrose octastearate, or mixtures thereof) must be melted before being added to the dry ingre-dientlliquid mixture. This allows ~or optimum distribution of the polyol polyester in the cookie dough.
METHOD OF TREATMENT
A treatment regimen of the present invention comprises oral administration to a patient in need of treatment to alleviate gastrointestinal disorders, such as irritable bowel syndrome, constipation or diarrhea, of a safe and ef~ective amount of a cookie containing psyllium seed gum, or source thereof made according to the process of the prcsent invention. By "safe and effectlve amount" is meant an amount sufficient to al leviate the gastrointestinal disorders but not so much as to cause any undesirable side-effects le.g., excess laxation). Ingestion of a total of from about 5 9 to about 15 9 of psyllium material per day is appropriate in most circumstances to relieve these conditions.
' This can be accomplished by daily ingestion of from about 4 to about 8, preferably about 6, cookies each containing from about 1 g to about 5 g of the psyllium materialu Preferably said ingestion is at two or three regularly spaced intervals throughou~ the day.
This can vary somewhat with the size and condition of the patient. Such matters will, of course, be apparent to the attend--` 35 ing physician. However, since the psyllium material is nontoxic and nonallergenic, even higher ingestion levels can be used :. ;

,. : . :
: :

1 32q777 without undue side effects, keeping in mind that excess psyllium can have a laxative effect.
If the patient suffers from chronic gastrointestinal disorders, including irritable bowel syndrome, constipation or diarrhea, 5 chronic ingestion of from about 4 to about 8 cookies per day may be appropriate.
A second method of treatment aspect of the present invention comprises oraliy administering to a patient having hyperchoJes-terolemia a safe and effective amount of 3 cookie (made as de-10 scribed herein] comprising either psyllium seed gum, or sourcethereof, or a combination of psyllium seed gum or source thereof, and a nonabsorbable, nondigestible polyol polyester of the type described hereinabove. By "safe and effective amount" is meant an amount sufficient to reduce blood cholesterol to normal levels 15 but not so much as to cause any undesirable sicle effects ~e.g., excess laxation or anal leakage). Ingestion of a daily total of from about 5 g to about 15 g of psyllium material, or ingestion of a daily total of from about 5 g to about 15 g of psyllium material and from about 10 g to about 30 9 of the polyester material is 20 appropriate in most circumstances. This can be accompiished by dai Iy ingestion of from about 4 to about 8, preferably about 6, cookies each containing either from about 1 g to about 5 9 of psyllium material, or from about 1 g to about 5 g of psyllium material and from about 3 g to about 15 g of the polyest@r 25 material at two or three regularly spaced intervals throughout the day. This treatment regimen is continued until the sondition is relieved. This can vary somewhat with the size and condition of the patient, ancl the patient's blood oholesterol level. 5uch matters will, of course, be apparent to the attending physician.
30 However, since the psyl!ium material and the polyol material are nontoxic and nonallergenic, even higher ingestion levels can be used without undue side effects, keeping in mind that the materials herein do have a laxative effect.
In a preferred embodiment, to enhance ease of usage in a 35 treatment regimen, the cookies are formulated such that they each , .
~, .

~ 32~777 contain a pharmaceutical unit dosage amount of the psyllium and~or polyol polyester components.
The prçferred polyol polyesters used in the foregoing meth-ods are: sucrose octaoleate, sucrose ostalinoleate, sucrose ~ta-5 stearate, sucrose octapalmitate and mixtures thereof.
The following examples illustrate the present invention. Itwill be appreciated that other modifications of the present inven-tion, wlthin the skill of those in the baked food and pharmaceu-tical arts, can be undertaken without departing from the spirit 10 and scope of this invention.
All percentages and ratios herein are by weight unless otherwise indicated.
EXAMPLE I
A peanut butter cookie containing psyllium is prepared as fol lows:
Amount (gJ
Brown Sugar 85 . 00 Water 26 . 28 Baking Soda 3.G0 Salt 1.00 Shortening* 120. 00 Flour*~ 28 . 80 Pregelatinized Starch*~* 14. 00 Psyllium 61. 20 Dry Egg White Solids 3.72 Baking Powder 2 . 00 Sucrose 85 . 00 Peanut Butter 110. 00 Crisco Brand - available from The Procter ~ Gamble Company 30 **AII purpose wheat flour, e.g., Gold Medal brand (General Mills) ***Tenderge~34 available ~rom A. E. Staley Company The brown sugar, water, baking soda and salt are first combined using a Hobart mixer. The shortening is then combined ;` with this premix composition. The flour, pregelatinized starch, 35 psyllium, dry egg white solids and the baking powder are mixed together and then combined with the above ingredients. The ~ . ~' ' ' , .
~ ~: . ;.
, ., .. ~ . . ..

.,, '' ,, - " ~ .. . ,., , :
.

1 32q777 sucrose is added and mixed in . Final Iy the peanut butter is mixed in. Fi~een gram portions of the cookie dough are then placed equidistant from each other on a baking sheet and baked in a Baker Perkins Mini~Rotel oven at 375F for a~out 13 minutes.
5The result is a cookie which has the texture and taste of a conventional peanut butter cookie but which provides a means for introducting psyllium into the diet. Ingestion of 5iX of these cookies per day, taken in portions of two cookies at three regu-larly spaced intervals throughout the day, can be used to reduce 10blood cholesterol level. Alternatively, this same regimen of ingestion of the cookie can also be used to treat gastrointestinal disorders in a patient in need of such treatment.
Similar results are obtained whsn the flour component, defined above, is included in the premix composition. Similar 15results are also obtained when fre5h whole Pg9 is used in the premix step in place of an equivalent amount of water and dry egg white solids.
Substantially similar results are obtained if the Crisco is replaced, in whole or in part, with corn oil, palm oil, hydroge-20nated palm oil, lard or tallow oil, or mixtures thereof.
Substantially similar results are obtainecl if the wheat flour of this example is replaced, in whole or in part, with a cake flour, a synthetic flour, triticale or oat flour, or mixtures thereof. Substantially similar results are also obtained if starch 25is substituted for all or part of the flour component. The pre-gelatinized starch may be replaced, in whole or in part, with potato starch, corn starch, wheat starch, rice starch, bariey starch, oat starch, tapioca starch, arrowroot, or sago starch, or mixtures thereof. Substantially similar results are also obtained 30if the brown sugar or sucrose are replaeed, in whole or in part, with dextrose, maltose, fructose, invert sugars, or corn syrups.
Substantially similar results are also obtained if the peanut butter is replaced, in whole or in part, with flavored bits, nuts, bran, oatmeal, spices, vanllla extract, orange flavoring, or mint 35 flavsring.

.
:: :

' ,'. ' . :

1 32q777 EXAMPLE l I
A peanut butter cookie containing psyllium and sucrose pclyester is pr~pared according to Example 1, but the 120 grams of shortening is replaced with 120 grams of sucrose polyester (a 5 mixture of sucrose hexa-, hepta- and octaesters of soybean oil fatty acids) which has first been melted. The resu3t is a cookie which has the texture and taste of a conventional cookie but which is significantly lower in calories and which provides a means for introducing psyllium and sucrose polyester into the 10 diet. Ingestion of six of these cookies per day, taken in portions of two cookies at three reyularly spaced intervals throughout the day, can be used to reduce blood cholesterol leveis.
132 mg of d-alpha-tocopherol acetate may be added to the above cookie dough to form a vitamln-supplemented version of the 1 5 cookies.
Substantially similar results are obtained if the Crisco is replaced, in whole or in part, with corn oil, palm oil, hydro-genated palm oil, lard or tallow oil, or mixtures thereof.
Substantially similar results are obtained if the wheat flour 20 of this example is replaced, in whole or in part, with a cake flour, a synthetic flour, triticale or oat flour, or mixtures thereof. Substantially similar results are also obtained if starch is substituted for all or part of the flour component. The pre-gela~inized starch may be replaced, in whole or in part, with 25 potato starch, corn starch, wheat stareh, rice s~arch, barley starch, oat starch, tapioca starch, arrowroot, or sago starch~ or mixtures thereof. Substantially similar results are also obtained if the brown suyar or sucrose are replaced, in whole or in part, with dextrose, maltose, fructose, invert sugars, or corn syrups~
30 Substantially simllar results are also obtained if the peanut butter is replaced, in whole or in part, with flavored bits, nuts, bran, oatmeal, spices, vanilla extract, orange flavoring, or mint , flavoring.

. . .

.
:;' .
, , ~ , .
-.

Claims (27)

1. A method for making a psyllium-containing cookie dough comprising the steps of:
(a) combining from about 3% to about 15%, by weight of the dough, of a liquid component selected from the group consisting of water, fresh egg, and mixtures thereof, with from about 0.6% to about 35%, by weight of the dough, of a dry ingredient component selected from the group consisting of sugar, flour, non-pre-gelatinized starch, egg solids, protein solids, and mixtures thereof;
(b) combining from about 10% to about 35% by weight of the dough, of a fluid shortening component with the mixtures of (a); and (c) combining the mixture of (b) with from about 5% to about 30%, by weight of the dough, of a psyllium component, and other conventional cookie components to form said dough.
2. The method of Claim 1 which further comprises forming the dough into from about 10 g to about 30 g cookie portions.
3. The method of Claim 2 which further comprises baking the cookie dough portions at a temperature of from about 149°C to about 190°C for from about 5 minutes to about 15 minutes.
4. The method of Claim 3 wherein the dry ingredient com-ponent comprises sugar.
5. The method of Claim 4 wherein the dry ingredient com-ponent comprises sucrose.
6. The method of Claim 3 wherein from about 10% to about 100%, of the shortening component comprises a premelted, nondigestible, nonabsorbable, polyol polyester.
7. The method of Claim 6 wherein the polyol polyester is selected from the group consisting of sucrose octaoleate, sucrose octastearate, sucrose octalinoleate, sucrose octapalmitate, and mixtures thereof.
8. A method for making a psyllium-containing cookie dough comprising the steps of:
(a) combining from about 3% to about 15%, by weight of the dough, of a liquid component selected from the group consisting of water, fresh egg, and mixtures thereof, with from about 10% to about 30%, by weight of the dough, of a sugar component;
(b) combining from about 10% to about 35%, by weight of the dough, of a fluid shortening component with the mixture of (a);
(c) mixing together from 0% to about 30%, by weight of the dough, of a flour component, from 096 to about 30%, by weight of the dough, of a starch component, from about 0.1%
to about 2%, by weight of the dough, of a dry egg white component, and from about 5% to about 30%, by weight of the dough, of a psyllium component, and then combining this mixture with the mixture of (b).
9. The method of Claim 8 wherein the dough is formed into from about 10g to about 30g cookie portions.
10. The method of Claim 9 wherein the cookie portions are baked at a temperature of from about 149°C to about 190°C for from about 5 minutes to about 15 minutes.
11. The method of Claim 10 wherein the sugar component comprises sucrose.
12. The method of Claim 10 wherein the flour component comprises all-purpose wheat flour.
13. The method of Claim 10 wherein the liquid component comprises water.
14. The method of Claim 10 wherein the starch component comprises pregelatinized starch.
15. The method of Claim 10 wherein the shortening component comprises a hydrogenated soybean-based shortening.
16. The method of Claim 10 wherein from about 10% to about 100% of the shortening component comprises a premelted, nondigestible, nonabsorbable, polyol polyester.
17. The method of Claim 16 wherein the polyol polyester is selected from the group consisting of sucrose octaoleate, sucrose octalinoleate, sucrose octapalmitate, sucrose octastearate and mixtures thereof.
18. The product of the process of Claim 3.
19. The product of the process of Claim 6.
20. The product of the process of Claim 10.
21. The product of the process of Claim 16.
22. A cookie comprising:
(a) from about 5% to about 30% of psyllium;
(b) from about 10% to about 3596 of a shortening component comprising from about 10% to about 100%
of a premelted, nondigestible, nonabsorbable polyol polyester;
(c) from about 25% to about 50% of a sugar component;
(d) from 0% to about 3096 of a flour component;
(e) from 0% to about 30% of a starch component;
(f) from 0% to about 15% of an egg component;
(g) the remainder being conventional cookie additives.
23. The cookie of Claim 22 wherein the shortening component comprises from about 50% to about 100% of the polyol polyester.
24. The cookie of Claim 23 wherein the polyol polyester is selected from the group consisting of sucrose octaoleate, sucrose octalinoleate, sucrose octapalmitate, sucrose octastearate and mixtures thereof.
25. A cookie comprising (a) from about 8% to about 25% of psyllium;
(b) from about 15% to about 35% of a polyol polyester salected from the group consisting of sucrose octaoleate, sucrose octalinoleate, sucrose octastearate, sucrose octapalmitate and mixtures thereof;
(c) from about 30% to about 45% of sucrose;
(d) from about 0% to about 15% of an all-purpose wheat flour;
(e) from about 1% to about 5% of pregelatinized starch;
(f) from about 0.1% to about 2% of dry egg white solids;
(g) the remainder being conventional cookie additives.
26. A pharmaceutical composition for the treatment of gastrointestinal disorders made according to the method of Claim 3 comprising a unit dosage amount of a psyllium component.
27. A pharmaceutical composition for the treatment of high serum cholesterol levels made according to the method of Claim 16 comprising a unit dosage amount of a psyllium component and a unit dosage amount of a non-digestible, non absorbable polyol polyester.
CA000577241A 1987-09-14 1988-09-13 Cookies containing psyllium Expired - Fee Related CA1329777C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/096,685 US4950140A (en) 1987-09-14 1987-09-14 Cookies containing psyllium
US96,685 1987-09-14

Publications (1)

Publication Number Publication Date
CA1329777C true CA1329777C (en) 1994-05-24

Family

ID=22258578

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000577241A Expired - Fee Related CA1329777C (en) 1987-09-14 1988-09-13 Cookies containing psyllium

Country Status (10)

Country Link
US (1) US4950140A (en)
EP (1) EP0309029B1 (en)
JP (1) JPH01157337A (en)
AT (1) ATE82467T1 (en)
AU (2) AU628020B2 (en)
CA (1) CA1329777C (en)
DE (1) DE3876054T2 (en)
ES (1) ES2045090T3 (en)
GR (1) GR3006320T3 (en)
MX (1) MX169969B (en)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5095008A (en) * 1987-09-14 1992-03-10 The Procter & Gamble Company Cookies containing psyllium
US5910317A (en) * 1988-01-11 1999-06-08 The Procter & Gamble Company Mixed compositions for treating hypercholesterolemia
GB8815224D0 (en) * 1988-06-27 1988-08-03 Unilever Plc Bakery-margarine composition
DE69002492T2 (en) * 1989-03-16 1993-12-02 Procter & Gamble Cookies containing psyllium with a high fiber content.
USRE36067E (en) * 1989-03-29 1999-01-26 Kellogg Company R-T-E cereal with psyllium
US5024996A (en) * 1989-12-05 1991-06-18 General Mills, Inc. R-T-E cereal with soluble fibers
US5026689A (en) * 1989-03-29 1991-06-25 General Mills, Inc. R-T-E cereal with psyllium
US5102664A (en) * 1989-07-19 1992-04-07 Day Charles E Good-tasting gritty drug formulations
US5219570A (en) * 1989-08-10 1993-06-15 The Procter & Gamble Company Agglomerated psyllium husk containing edible acid
US5015486A (en) * 1989-09-11 1991-05-14 General Mills, Inc. Dry mix for microwave muffins with psyllium and method of preparation
US5227248A (en) * 1989-09-27 1993-07-13 Kellogg Company Ready-to-eat cereal containing psyllium
US5223298A (en) * 1989-09-27 1993-06-29 Kellogg Company Ready-to-eat cereal containing psyllium and method of producing the same
US5464644A (en) * 1989-09-27 1995-11-07 Kellogg Company Ready-to-eat-cereal containing psyllium and use thereof for lowering cholesterol levels
US5110614A (en) * 1989-12-14 1992-05-05 Microgold Process of making a microwaveable bakery product
EP0435364B1 (en) * 1989-12-21 1995-04-05 Unilever N.V. Process for refining organic-solvent containing crude polyol fatty-acid polyester products
US6419911B1 (en) * 1993-09-17 2002-07-16 Board Of Trustees Of Michigan State University Psyllium containing snack bars, processes for making these, and uses thereof
US5126150A (en) * 1990-10-01 1992-06-30 The Procter & Gamble Company Compositions containing psyllium
US5576306A (en) * 1991-03-01 1996-11-19 Dow Chemical Company Pharmaceutical compositions and uses of water-soluble, high-viscosity grade cellulose ethers
US5721221A (en) * 1991-03-08 1998-02-24 Regents Of The University Of Minnesota Lowering blood cholesterol levels using water soluble cellulose ethers
EP0506166A3 (en) * 1991-03-25 1993-01-13 Unilever N.V. Ingestible material
US5294451A (en) * 1991-03-29 1994-03-15 Curtice-Burns, Inc. Fat substitute compositions having reduced laxative effects
US5366753A (en) * 1991-03-29 1994-11-22 Curtice-Burns, Inc. Fat substitute compositions having reduced laxative effects at low levels of inclusion
US5234687A (en) * 1991-10-21 1993-08-10 The Procter & Gamble Company Method of making an unflavored psyllium drink mix
US5248502A (en) * 1991-11-08 1993-09-28 Kellogg Company Method for decreasing the allergenicity of psyllium seed husk by alkaline treatment
US5244887A (en) * 1992-02-14 1993-09-14 Straub Carl D Stanols to reduce cholesterol absorption from foods and methods of preparation and use thereof
US5281584A (en) * 1992-02-28 1994-01-25 The Dow Chemical Company Effect of particle-size distribution of cellulose ethers on palatability of compositions
US5258181A (en) * 1992-03-02 1993-11-02 The Procter & Gamble Company Compositions containing psyllium
CA2131177C (en) * 1992-03-11 1997-08-05 Hing Cheung Tse Psyllium drink mix compositions containing granulated base
WO1993018756A1 (en) * 1992-03-20 1993-09-30 The Procter & Gamble Company Anion exchange resin compositions
US5234916A (en) * 1992-06-12 1993-08-10 The Proctor & Gamble Company Psyllium drink mix compositions
US5232698A (en) * 1992-06-12 1993-08-03 The Proctor & Gamble Company Psyllium drink mix compositions
US5356618A (en) * 1993-05-14 1994-10-18 The Procter & Gamble Company Psyllium drink mix compositions
US5384136A (en) * 1993-09-17 1995-01-24 Kellogg Company Psyllium-enriched dough products and method for making the same
US5384144A (en) * 1993-09-17 1995-01-24 Kellogg Company Psyllium enriched pasta products and method for making same
US5665376A (en) * 1994-02-09 1997-09-09 Russo; Ubaldo Method for reducing excessive stomach acid
US5576001A (en) * 1995-02-22 1996-11-19 Abu-Shaaban; Medhat Composition for the treatment of diarrhea, its use and its preparation
US5651988A (en) * 1995-08-18 1997-07-29 Xyrofin Oy Combination osmotic and bulk forming laxatives
US5766638A (en) * 1995-12-08 1998-06-16 The Dow Chemical Company Hydroxypropyl methocellulose ether compositions for reduction of serum lipid levels
US5955123A (en) * 1996-10-21 1999-09-21 The Procter & Gamble Company Baked compositions comprising psyllium
US6013299A (en) 1997-11-04 2000-01-11 Nabisco Techology Company Process for making enzyme-resistant starch for reduced-calorie flour replacer
US5976598A (en) * 1997-11-04 1999-11-02 Nabisco, Inc. Physically coated cellulose as low calorie flour replacements
WO2000021375A1 (en) * 1998-10-14 2000-04-20 Foco Method and composition for replacing part of whole liquid eggs in a bakery product with a composition comprising a powder egg white or the like
US6291006B1 (en) * 1999-07-30 2001-09-18 The Procter & Gamble Co. Dissolution agent and process for making rapidly soluble instant beverage products
GB0008657D0 (en) * 2000-04-07 2000-05-31 Mars Uk Ltd Pet food
US7182968B2 (en) * 2001-01-11 2007-02-27 Fran Gare Composition containing xylitol and fiber
US20050058759A1 (en) * 2003-09-15 2005-03-17 Schmidt James Carl Protein enhanced low carbohydrate snack food
US9668488B2 (en) * 2004-06-22 2017-06-06 Healthy Fiber, LLC Calorie reduction-taste retention food products
US20060008564A1 (en) * 2004-07-08 2006-01-12 Pzena Wendy M Cholesterol-lowering batter-based food composition and method for making same
US7648723B2 (en) 2005-10-26 2010-01-19 Kraft Foods Global Brands Llc Production of low calorie, extruded, expanded foods having a high fiber content
US7977319B1 (en) 2006-04-03 2011-07-12 Scott David Levine Ultra-high fiber supplement and method of reducing weight, cardiovascular risks and ingested toxins
US7556832B2 (en) * 2006-05-09 2009-07-07 Kracke Donald R Process and formula for treating irritable bowel syndrome
US20080138472A1 (en) * 2006-12-12 2008-06-12 Delse Alexandre High fiber rotary molded cookies containing inulin and resistant starch
US20090297659A1 (en) * 2008-06-03 2009-12-03 Boutte Troy T Enzymatic dough conditioner and flavor improver for bakery products
BRPI0920769B1 (en) 2008-11-21 2017-09-12 The Quaker Oats Company Whole grain oatmeal that can be baked in a microwire oven, its method of preparation, baked product, and method of forming a baked product
US9145396B2 (en) * 2008-12-01 2015-09-29 Targacept, Inc. Synthesis and novel salt forms of (R)-5-((E)-2-pyrrolidin-3ylvinyl)pyrimidine
WO2010111486A2 (en) 2009-03-27 2010-09-30 The Procter & Gamble Company Food products
US20100247718A1 (en) * 2009-03-27 2010-09-30 Scott Donald Whalen Food Products
US20110027412A1 (en) * 2009-07-31 2011-02-03 Kris Eugene Spence Compositions and Methods for Promoting Gastrointestinal and/or Cardiovascular Health
JP5654244B2 (en) * 2010-01-29 2015-01-14 花王株式会社 Baked goods
JP5832762B2 (en) * 2011-03-03 2015-12-16 株式会社明治 Method for producing baked goods
ES2471340B1 (en) 2012-12-21 2015-08-17 Laboratorios Rubió, S.A. Oral pharmaceutical composition for high dosage drugs
JOP20180047A1 (en) * 2018-05-02 2019-11-02 Univ Of Jordan Low - protein flour mix composition

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2831854A (en) * 1955-05-24 1958-04-22 Procter & Gamble Method for preparing fatty esters of non-reducing oligosaccharides in the presence of an amide
US3219455A (en) * 1963-07-11 1965-11-23 Hercules Powder Co Ltd Bread and additive
US3455714A (en) * 1964-09-01 1969-07-15 Hercules Inc Cellulose derivatives of improved dispersibility and process
US3600186A (en) * 1968-04-23 1971-08-17 Procter & Gamble Low calorie fat-containing food compositions
US3579548A (en) * 1968-05-10 1971-05-18 Procter & Gamble Triglyceride esters of alpha-branched carboxylic acids
FR2165795A1 (en) * 1971-12-31 1973-08-10 Tuillier Arlette Laxative biscuits - contg a mucilage
US3954976A (en) * 1973-12-14 1976-05-04 The Procter & Gamble Company Pharmaceutical compositions for inhibiting absorption of cholesterol
US3963699A (en) * 1974-01-10 1976-06-15 The Procter & Gamble Company Synthesis of higher polyol fatty acid polyesters
DE2430509A1 (en) * 1974-06-25 1976-01-15 Hypolab Sa Laxative cake - contg one or more bulk laxatives as active ingredient
US4034083A (en) * 1975-11-03 1977-07-05 The Procter & Gamble Company Compositions for inhibiting absorption of cholesterol
US4005195A (en) * 1976-02-12 1977-01-25 The Procter & Gamble Company Compositions for treating hypercholesterolemia
US4005196A (en) * 1976-02-12 1977-01-25 The Procter & Gamble Company Vitaminized compositions for treating hypercholesterolemia
US4156021A (en) * 1976-03-03 1979-05-22 Maxfibe, Inc. Oleaginous fibrous simulated food product
DE2821015A1 (en) * 1977-05-20 1978-11-30 Syntex Inc DIET TABLE PREPARATION
US4241054A (en) * 1978-12-08 1980-12-23 The Procter & Gamble Company Detoxifying lipophilic toxins
DE2919449C2 (en) * 1979-05-15 1981-08-06 Kowalsky, Horst, Dr.med., 5000 Köln Dietary agent for natural digestive regulation
US4264583A (en) * 1979-07-25 1981-04-28 The Procter & Gamble Company Gallstone dissolution compositions and method
US4382924A (en) * 1980-06-25 1983-05-10 The Procter & Gamble Company Palatable composition containing oil or oil-like materials
US4321263A (en) * 1980-09-30 1982-03-23 Rowell Laboratories, Inc. Psyllium compositions
US4368213A (en) * 1981-06-23 1983-01-11 The Procter & Gamble Company Emulsion concentrate for palatable polyester beverage
US4461782A (en) * 1982-02-16 1984-07-24 The Procter & Gamble Company Low calorie baked products
US4673578A (en) * 1983-05-11 1987-06-16 Warner-Lambert Company Snack food product with high dietary fiber content and process for producing the same
US4568557A (en) * 1983-05-11 1986-02-04 Warner-Lambert Company Process for producing snack food product with high dietary fiber content
US4517360A (en) * 1983-06-23 1985-05-14 The Procter & Gamble Company Synthesis of higher polyol fatty acid polyesters using carbonate catalysts
US4518772A (en) * 1983-06-23 1985-05-21 The Proctor & Gamble Company Synthesis of higher polyol fatty acid polyesters using high soap:polyol ratios
US4668522A (en) * 1983-09-09 1987-05-26 The Procter & Gamble Company Mixing process for cookies with storage-stable texture variability
DE3479630D1 (en) * 1983-12-12 1989-10-12 Procter & Gamble Psyllium mucilloid products
US4668519A (en) * 1984-03-14 1987-05-26 Nabisco Brands Reduced calorie baked goods and methods for producing same
US4619831A (en) * 1984-06-04 1986-10-28 Warner-Lambert Company Dietary fiber composition and process of manufacture
US4565702A (en) * 1984-06-04 1986-01-21 Warner-Lambert Company Dietary fiber food products and method of manufacture
US4766004A (en) * 1986-12-19 1988-08-23 Warner-Lambert Company Crunchy, highly palatable, bulk-increasing, dietary fiber supplement composition
US4849222A (en) * 1987-03-24 1989-07-18 The Procter & Gamble Company Mixtures for treating hypercholesterolemia

Also Published As

Publication number Publication date
DE3876054D1 (en) 1992-12-24
AU2043992A (en) 1992-10-08
AU660474B2 (en) 1995-06-29
AU628020B2 (en) 1992-09-10
JPH01157337A (en) 1989-06-20
ATE82467T1 (en) 1992-12-15
GR3006320T3 (en) 1993-06-21
DE3876054T2 (en) 1993-04-01
EP0309029A1 (en) 1989-03-29
AU2218388A (en) 1989-03-16
ES2045090T3 (en) 1994-01-16
US4950140A (en) 1990-08-21
EP0309029B1 (en) 1992-11-19
MX169969B (en) 1993-08-03

Similar Documents

Publication Publication Date Title
CA1329777C (en) Cookies containing psyllium
US5095008A (en) Cookies containing psyllium
US5281584A (en) Effect of particle-size distribution of cellulose ethers on palatability of compositions
EP0086527B1 (en) Low calorie baked products
AU620541B2 (en) Mixtures for treating hypercholesterolemia
CA1069434A (en) Compositions for inhibiting absorption of cholesterol
EP0387933B1 (en) High fiber baked cookies containing psyllium
EP0726030B1 (en) Reduced calorie fat component
EP0571219B1 (en) Esterified propoxylated glycerin fat substitute compositions resistant to gastrointestinal side effects
US5955123A (en) Baked compositions comprising psyllium
EA003833B1 (en) Food composition, comprising oil-in-water emulsion of triglyceride oils and use of emulsion as food product for preparing of food and pharmaceutical compositions
EP0388319A1 (en) Material for food and method for production thereof
EP0347014A1 (en) Edible, baked compositions containing cholestyramine
CA2012707A1 (en) Partially digestible sucrose esters as low calorie fat mimetics
USH937H (en) Bulking agent for baked products
EP0375031A2 (en) Low-calorie food products
JPS6339568B2 (en)
CA2006132A1 (en) Low-calorie food products
Swanson et al. I. CARBOHYDRATE FATTY ACID ESTERS

Legal Events

Date Code Title Description
MKLA Lapsed